What should clinicians tell patients about placebo and nocebo effects? Practical considerations based on expert consensus

Author(s):: Evers, A.W.M.; Colloca, L.; Blease, C.; Gaab, J.; Jensen, K.B.; Atlas, L.Y.; Beedie, C.J.; Benedetti, F.; Bingel, U.; Büchel, C.; Bussemaker, J.; Colagiuri, B.; Crum, A.J.; Finniss, D.G.; Geers, A.L.; Howick, J.; Klinger, R.; Meeuwis, S.H.; Meissner, K.; Napadow, V.; Petrie, K.J.; Rief, W.; Smeets, I. (0000-0003-1743-9493); Wager, T.D.; Wanigasekera, V.; Vase, L.; Kelley, J.M.; Kirsch, I.

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-10-19
Language: English
Is part of: Psychotherapy and Psychosomatics (2020), Vol. 90, no. 1, p. 49-56
hdl: 1887/3134690
doi: 10.1159/000510738
URL: https://www.karger.com/Article/Abstract/510738